BEDMINSTER, N.J., May 25, 2022 (GLOBE NEWSWIRE) -- TYME Technologies, Inc. (Nasdaq:TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsâ„¢), announced financial and operating results for its fourth fiscal quarter and full year ended March 31, 2022.
TYME Technologies, Inc. Reports Fourth Fiscal Quarter and Full Year 2022 Financial and Operating Results
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here